0001140361-15-028636.txt : 20150724 0001140361-15-028636.hdr.sgml : 20150724 20150724212808 ACCESSION NUMBER: 0001140361-15-028636 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150722 FILED AS OF DATE: 20150724 DATE AS OF CHANGE: 20150724 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEVIVO JOSEPH CENTRAL INDEX KEY: 0001258790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 151005754 4 1 doc1.xml FORM 4 X0306 4 2015-07-22 0 0001275187 ANGIODYNAMICS INC ANGO 0001258790 DEVIVO JOSEPH 14 PLAZA DRIVE LATHAM NY 12110 1 1 0 0 President and CEO Common Stock 2015-07-22 4 A 0 28061 0 A 207241 D Non-Qualified Stock Option (right to buy) 15.95 2015-07-22 4 A 0 96251 0 A 2016-07-22 2022-07-22 Common Stock 96251 96251 D Performance Right 2015-07-22 4 A 0 37414 0 A Common Stock 37414 37414 D 1. This acquisition of 28,061 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 28,061 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units will vest on each of July 22, 2016, 2017, 2018 and 2019. These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options will vest on each of July 22, 2016, 2017, 2018 and 2019. Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited. /s/ Stephen A. Trowbridge, Attorney in Fact 2015-07-24